D
LIVE

Serial Number

79278708

Owner

Zahorii Hlib Volodymyrovych

Attorney

Kenneth Motolenich-Salas

Filing Date

Aug 28, 2019

Add to watchlist:

No watchlists yet
View on USPTO

D Trademark

Serial Number: 79278708 • Registration: 6235899

D is a trademark filed by Zahorii Hlib Volodymyrovych on August 28, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Zahorii Hlib Volodymyrovych (3 trademarks)

13 Boryspilska Street

Entity Type: 01

Trademark Details

Filing Date

August 28, 2019

Registration Date

January 5, 2021

Published for Opposition

October 20, 2020

Goods & Services

Antiseptics; vaccines; veterinary preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vitamin preparations; disinfectants; diagnostic preparations for veterinary purposes; diagnostic preparations for medical purposes; dietetic beverages adapted for medical purposes; Dietetic foods and beverages adapted for medical use; dietetic foods adapted for medical purposes; plant extracts for pharmaceutical purposes; herbal extracts for medical purposes; Capsules sold empty for pharmaceuticals; medicinal preparations for human purposes for medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Drugs being pharmaceutical preparations for medical purposes for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Medicinal drinks; medicinal oils; medicated toiletry preparations; medicated shampoos; ointments for pharmaceutical purposes, namely, medicated ointments for treating dermatological conditions and antibiotic ointments; teeth filling material; medicinal alcohol; food supplements; medical dressings; nutritional supplements; Pre-filled syringes containing pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Air purifying preparations; food for babies; protein dietary supplements; Tissues impregnated with pharmaceutical lotions for treating dermatological conditions; Alcohol for pharmaceutical purposes; stem cells for medical purposes; transplants, namely, surgical implants comprising living tissue used in transplant operations; pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; ferments for pharmaceutical purposes; phytotherapy preparations for medical purposes; chemico-pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Chemical preparations for medical purposes for the diagnosis of pregnancy; Chemical preparations for pharmaceutical purposes for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; surgical dressings; candy, medicated; candy for medical purposes; sanitary preparations for medical purposes, namely, medicated toiletry preparations; plasters for medical purposes

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 5, 2026 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Feb 28, 2025 NREP
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 3, 2023 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 3, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 3, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 3, 2023 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
May 2, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 11, 2021 FICS
FINAL DISPOSITION PROCESSED
Apr 10, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 5, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 5, 2021 R.PR
NEW REPRESENTATIVE AT IB RECEIVED
Dec 18, 2020 NREP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 20, 2020 NPUB
PUBLISHED FOR OPPOSITION
Oct 20, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Oct 18, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 30, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 30, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 30, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 15, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 14, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 14, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 14, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 14, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 1, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 1, 2020 CRFA
ASSIGNED TO LIE
Aug 31, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 13, 2020 TROA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 12, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 12, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 12, 2020 TROA
REFUSAL PROCESSED BY IB
Mar 28, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 11, 2020 RFCS
REFUSAL PROCESSED BY MPU
Mar 11, 2020 RFRR
APPLICATION FILING RECEIPT MAILED
Feb 25, 2020 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 20, 2020 RFCR
NON-FINAL ACTION WRITTEN
Feb 19, 2020 CNRT
ASSIGNED TO EXAMINER
Feb 19, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 19, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 13, 2020 REPR